NEW YORK–(BUSINESS WIRE)–Ophthotech announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present at the Goldman Sachs 37th Annual Global Healthcare Conference
Category: News
Pixium Vision Receives Clinical Trial Approval From UK Regulatory Authority for 150 Electrode IRIS®II Bionic Vision System
PARIS–(BUSINESS WIRE)–Pixium Vision (Paris:PIX) (FR0011950641 – PIX), a company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives, today announced that it has received approval from the Medicines & Healthcare products Regulatory Agency (MHRA) in the UK to initiate a clinical trial for patients who have lost sight due to retinitis pigmentosa (RP) with the IRIS® II bionic vision system. This system being evaluated includes
Coffee might prevent exercise-induced eye fatigue
Researchers found that 3 hours of cycling slowed rapid eye movement, but drinking the equivalent of two cups of coffee counteracted this effect.
D.C. Week: Implant for Opioid Addiction Wins FDA Approval
(MedPage Today) — Also: shuttering pill mills may have unintended consequences
Vitamin D Deficiency Linked to Diabetic Retinopathy
A systematic review and meta-analysis find association, but the mechanism isn’t clear, and no randomized clinical trials of supplementation have been conducted as yet. Medscape Medical News
Retinopathy Linked to Vitamin D Deficiency (CME/CE)
(MedPage Today) — Meta-analysis finds connection between eye disease and low levels of the vitamin
Zika Linked to Eye Abnormalities in Babies (CME/CE)
(MedPage Today) — Risk factors include Zika infection in the first trimester
Added Benefits Seen With Early Initiation of Anti-VEGF Agents for Diabetic Retinopathy
Dr Charles C. Wykoff reviews recent data showing that more timely treatment has a significant upside. Medscape Ophthalmology
Zika virus may be linked to more eye problems in Brazilian babies with microcephaly
Ophthalmologists find retinal bleeding, abnormal blood vessel development and lesions in infants born to mothers who showed signs of the viral infection during pregnancy.
Acucela Announces Top-Line Results from Phase 2b/3 Clinical Trial of Emixustat
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, announced today top-line results from the Phase 2b/3 clinical trial (S.E.A.T.T.L.E. study) of the investigational visual cycle modulator emixustat hydrochloride (emixustat). The study enrolled 508 patients with geographic atrophy (GA) secondary to age-
Zika virus infection may cause ocular problems in Brazilian infants with microcephaly
Researchers studying babies with a Zika virus-related birth defect say they have found previously unreported eye problems possibly linked to the virus that could result in severe visual impairment.
ADHD: Do the Eyes Have It?
A new study provides more evidence that elevated ‘background noise’ on pattern electroretinogram may be a neural correlate of ADHD. Medscape Medical News
5 Key Ophthalmology Takeaways: ASCRS 2016
Attendees in New Orleans were greeted with innovative theories and technologies that may change our treatment of glaucoma, cataracts, corneal ectasia, and other ophthalmic conditions. Medscape Ophthalmology
Global Glass Lens Market 2016-2020 with Essilor, HOYA, Luxottica & Zeiss Dominating – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Glass Lens Market 2016-2020” report to their offering. The global glass lens market to grow at a CAGR of 3.55% during the period 2016-2020. Global Glass Lens Market…
The Case of the Blue/Brown-Eyed Girl
A 2-year-old girl presents with unusual pigmentation in one eye and hearing issues. Can you make the correct diagnosis? Medscape Ophthalmology
South Carolina Bans Remote Exams for Eyeglass Prescriptions
Optometrists’ and ophthalmologists’ associations differ on whether the exams and prescriptions are safe for patients; 10 states now have similar bans. Medscape Medical News
Presbia to Participate in Jefferies 2016 Global Healthcare Conference
DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed and is currently marketing the Presbia Flexivue Microlens™, a proprietary optical lens implant for treating presbyopia, announced today that Todd Cooper, President and CEO, is scheduled to present at the Jefferies 2016 Global Healthcare Conference on Tuesday, June 7, 2016 at 10:00 a.m. ET. The Conference is being held from June 7 to 10, 2016 in New York, NY
NIH-funded study finds visual impairment, blindness may double by 2050
With the youngest of the baby boomers hitting 65 by 2029, the number of people with visual impairment or blindness in the United States is expected to double to more than 8 million by 2050, according to projections based on the most recent census data …
CSU researchers develop colorful potatoes that are high in antioxidants, rich in nutrients
Purple potatoes might not be the first thing that comes to mind when trying to increase vitamin, mineral and antioxidant intake. However, a group of researchers from Colorado State University have recently developed potato varieties that satisfy these …
Research provides pathway toward creation of first broad-spectrum antiviral drug
By studying the rare person — about one in a million — who can fight off viral infections more effectively than everyone else, investigators at the Icahn School of Medicine at Mount Sinai have developed a strategy to help the rest of us achieve this …